Upstream Bio, Inc. (UPB)
5.34
+0.03
(+0.56%)
USD |
NASDAQ |
Sep 18, 16:00
5.35
+0.01
(+0.19%)
After-Hours: 20:00
Upstream Bio Price : 5.34 for Sept. 18, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | 5.32 | 5.41 | 5.21 | 5.34 | 1.001M |
| Sep 17, 2026 | 5.44 | 5.48 | 5.235 | 5.31 | 533871.0 |
| Sep 16, 2026 | 5.49 | 5.54 | 5.27 | 5.33 | 497240.0 |
| Sep 15, 2026 | 5.81 | 5.81 | 5.455 | 5.48 | 421266.0 |
| Sep 14, 2026 | 5.75 | 5.87 | 5.70 | 5.81 | 491023.0 |
| Sep 11, 2026 | 5.84 | 5.84 | 5.65 | 5.73 | 501307.0 |
| Sep 10, 2026 | 5.86 | 5.86 | 5.67 | 5.75 | 562411.0 |
| Sep 09, 2026 | 6.14 | 6.20 | 5.77 | 5.96 | 726236.0 |
| Sep 08, 2026 | 6.01 | 6.21 | 5.77 | 6.19 | 952239.0 |
| Sep 04, 2026 | 6.00 | 6.23 | 5.965 | 6.01 | 643267.0 |
| Sep 03, 2026 | 6.49 | 6.49 | 5.77 | 6.08 | 1.352M |
| Sep 02, 2026 | 6.62 | 6.98 | 6.41 | 6.48 | 515755.0 |
| Sep 01, 2026 | 6.58 | 6.72 | 6.50 | 6.55 | 476486.0 |
| Aug 31, 2026 | 6.64 | 6.77 | 6.44 | 6.62 | 895009.0 |
| Aug 28, 2026 | 6.71 | 6.79 | 6.60 | 6.69 | 445477.0 |
| Aug 27, 2026 | 7.11 | 7.14 | 6.78 | 6.79 | 335062.0 |
| Aug 26, 2026 | 7.18 | 7.31 | 6.90 | 7.13 | 432932.0 |
| Aug 25, 2026 | 6.68 | 7.18 | 6.55 | 7.18 | 554421.0 |
| Aug 24, 2026 | 7.00 | 7.11 | 6.46 | 6.61 | 538545.0 |
| Aug 21, 2026 | 6.91 | 7.006 | 6.85 | 6.97 | 434242.0 |
| Aug 20, 2026 | 7.48 | 7.555 | 6.745 | 6.85 | 592939.0 |
| Aug 19, 2026 | 7.04 | 7.53 | 6.91 | 7.515 | 574179.0 |
| Aug 18, 2026 | 7.28 | 7.435 | 6.73 | 6.85 | 461780.0 |
| Aug 17, 2026 | 7.02 | 7.19 | 6.86 | 7.14 | 852441.0 |
| Aug 14, 2026 | 6.95 | 7.14 | 6.80 | 7.07 | 688249.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Sutro Biopharma, Inc. | 15.34 |
| Compass Therapeutics, Inc. | 1.90 |
| ACADIA Pharmaceuticals, Inc. | 27.29 |
| Alnylam Pharmaceuticals, Inc. | 239.56 |
| Anika Therapeutics, Inc. | 20.81 |
Price Related Metrics
| PS Ratio | 91.76 |
| PEG Ratio | -0.0454 |
| Price to Book Value | 1.079 |
| Earnings Yield | -54.05% |
| Market Cap | 292.48M |
| PEGY Ratio | -0.0454 |